EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics

Qing Pei, Bowen Jiang, Dengyuan Hao, Zhigang Xie

Acta Pharmaceutica Sinica B · 2023-08 · 13 (8) · 3252-3276

DOI: 10.1016/j.apsb.2023.02.021 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2023-08. Verfasst von Qing Pei und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 238 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Jilin Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy has occupied the critical position in cancer therapy, especially towards the post-operative, advanced, recurrent, and metastatic tumors. Paclitaxel (PTX)-based formulations have been widely used in clinical practice, while the therapeutic effect is far from satisfied due to off-target toxicity and drug resistance. The caseless multi-components make the preparation technology complicated and aggravate the concerns with the excipients-associated toxicity. The self-assembled PTX nanoparticles possess a high drug content and could incorporate various functional molecules for enhancing the therapeutic index. In this work, we summarize the self-assembly strategy for diverse nanodrugs of PTX. Then, the advancement of nanodrugs for tumor therapy, especially emphasis on mono-chemotherapy, combinational therapy, and theranostics, have been outlined. Finally, the challenges and potential improvements have been briefly spotlighted.

Schlagwörter

Stichwörter der Autor:innen

ChemotherapyCombinational therapyHeterodimeric prodrugHomodimeric prodrugPaclitaxelPoly-prodrugSelf-assemblyTheranostics

Autor:innen und Institutionen

  • State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China.
  • School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei 230026, China.

Förderung

  • Natural Science Foundation of Jilin Province
  • National Natural Science Foundation of China

Zitieren

APA

Pei, Q., Jiang, B., Hao, D., & Xie, Z. (2023). Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics. Acta Pharmaceutica Sinica B, 13(8), 3252-3276. https://doi.org/10.1016/j.apsb.2023.02.021

Vancouver

Pei Q, Jiang B, Hao D, Xie Z. Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics. Acta Pharmaceutica Sinica B. 2023;13(8):3252-3276. doi:10.1016/j.apsb.2023.02.021

BibTeX
@article{Pei2023,
  author = {Pei, Qing and Jiang, Bowen and Hao, Dengyuan and Xie, Zhigang},
  title = {Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2023},
  volume = {13},
  number = {8},
  pages = {3252--3276},
  doi = {10.1016/j.apsb.2023.02.021}
}
Kostenlos starten →